[Featured Stock] 'Korean New Deal' Beneficiary 'Non-face-to-face Medical Care'... CareLabs '↑'

[Asia Economy Reporter Yoo Hyun-seok] Carelabs has been rising for three consecutive days. This appears to be influenced by the government's plan to concentrate over 100 trillion won in investment over the next five years as part of the 'Korean New Deal,' with 'non-face-to-face medical treatment' mentioned as a core task.

As of 3:06 PM on the 6th, Carelabs was trading at 21,600 won, up 3.10% (650 won) compared to the previous trading day.

On the 5th, the Ministry of Economy and Finance announced that the Korean New Deal, initially proposed at 76 trillion won, would be increased to over 100 trillion won, with detailed plans to be finalized and the 'Korean New Deal Comprehensive Plan' scheduled for release around mid-month.

The Korean New Deal focuses on fostering various digital industries, including developing data and artificial intelligence (AI) ecosystems and promoting non-face-to-face medical care and education. 'Non-face-to-face medical treatment' has been allowed on a limited basis since late February to prevent the spread of the novel coronavirus disease (COVID-19), permitting telephone consultations and prescriptions. Given some positive effects, the government has shown strong determination to actively nurture the related industry. Specifically, plans are being discussed to build video consultation infrastructure and enable doctors to prescribe while viewing videos as part of remote medical treatment measures.

On the 2nd, during the National Affairs Review and Coordination Meeting chaired by the Prime Minister, the expansion of non-face-to-face medical services was also mentioned as a topic under consideration.